Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2009 1
2013 2
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments.
Bhatta M, Shenoy GN, Loyall JL, Gray BD, Bapardekar M, Conway A, Minderman H, Kelleher RJ Jr, Carreno BM, Linette G, Shultz LD, Odunsi K, Balu-Iyer SV, Pak KY, Bankert RB. Bhatta M, et al. Among authors: loyall jl. J Immunother Cancer. 2021 Oct;9(10):e003148. doi: 10.1136/jitc-2021-003148. J Immunother Cancer. 2021. PMID: 34599030 Free PMC article.
Preclinical evaluation of cancer immune therapy using patient-derived tumor antigen-specific T cells in a novel xenograft platform.
Shenoy GN, Greene CJ, Bhatta M, Baroja ML, Loyall JL, Balu-Iyer SV, Kelleher RJ Jr, Carreno BM, Linette GP, Shultz LD, Bankert RB. Shenoy GN, et al. Among authors: loyall jl. Clin Transl Immunology. 2021 Feb 2;10(2):e1246. doi: 10.1002/cti2.1246. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33552509 Free PMC article.